Tempus Labs applies AI to clinical and molecular data to enable precision medicine decisions in oncology.

Chicago-based Tempus Labs, Inc. offers genomic sequencing and data analysis for real-time medical decisions in the US.
Founded in Chicago, Illinois, Tempus Labs, Inc. is a biotechnology company dedicated to transforming healthcare through the power of data and artificial intelligence. Their core mission is to provide genomic sequencing and data analysis to enable physicians to make real-time, data-driven medical decisions. Tempus offers services that include genomic sequencing and molecular data analysis, focusing primarily on oncology and other therapeutic areas within the United States.
Notable figures associated with Tempus Labs include its founder, Eric Lefkofsky, who is also known for co-founding Groupon. The company has attracted significant investment from high-profile venture capital firms and individual investors. Key achievements include partnerships with leading healthcare institutions and the development of AI-driven tools that have accelerated the discovery of novel therapeutic targets. Tempus Labs has made a substantial impact by integrating precision medicine into clinical practice, thereby improving patient outcomes through personalized treatment strategies.
Companies similar to Tempus include Cofactor Genomics, Ataraxis AI, Fuze Health and Foundation Medicine.
Tempus was founded in 2015.
Tempus' headquarters is located in Chicago, IL, US.
As of Jun 1, 2024, Tempus has disclosed funding of $1.3B (USD). Undisclosed round amounts are excluded.
Tempus has 2,421 employees as of Feb 5, 2024.

Cofactor Genomics

Ataraxis AI
ataraxis.ai

Fuze Health
fuzehealth.com

Foundation Medicine

Dnanexus
dnanexus.com

Nest Genomics
nestgenomics.com

Genomenon
genomenon.com

Data Driven Bioscience

ConcertAI
concertai.com

Ovation
ovation.io

Personalis
personalis.com

Owkin
owkin.com

Lifebit Biotech
lifebit.ai

Human Longevity
humanlongevity.com

GenomOncology
genomoncology.com